We are Montara Therapeutics, a San Francisco–based precision-medicine neuroscience biotech startup. Our team boasts significant experience from successful biotech firms such as Mitokinin, Denali, and Soteria, supported by a world-class Scientific Advisory Board (SAB).
We bring a new approach to tackling challenging established targets, along with unique experience in developing enzyme activators and domain expertise in mitophagy.
Our mission is to create innovative therapies for diseases of the CNS, with a focus on precision medicine and genetically validated targets to enhance drug safety and efficacy.
Company Details
- Employees
- 20
- Founded
- -
- Address
- 135 Mississippi St, San Francisco,california 94107,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.montaratx.com
- Keywords
- in mitophagy..
- HQ
- San Francisco, California
Montara Therapeutics, Inc. Questions
Montara Therapeutics, Inc.'s website is http://www.montaratx.com
Montara Therapeutics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/montara-therapeutics-inc
Montara Therapeutics, Inc. has
20 employees.
View email and phone details for 20
employees at Montara Therapeutics, Inc..
Montara Therapeutics, Inc.'s industry is
Biotechnology Research
Montara Therapeutics, Inc.'s top competitors are
Vilya,
Structure Therapeutics,
Maplight Therapeutics, Inc.,
Moonwalk Biosciences,
Genesis Therapeutics,
Kyverna Therapeutics,
Rezo Therapeutics,
Aralez Bio,
Cionic,
Evercrisp Biosciences.
Montara Therapeutics, Inc.'s categories are Biotechnology Research
Montara Therapeutics, Inc.'s founding year is 2023
